AiMeD Hails Govt's Move on New GST Regime Transition

The Association of Indian Medical Device Industry (AiMeD) has expressed its whole-hearted support for the latest instructions issued by the Department of Pharmaceuticals (DoP), National Pharmaceutical Pricing Authority

New GST Regime Lowers Cost of Drugs, Devices

The new GST regime, the government has instructed pharmaceutical companies to rework the maximum retail price (MRP) of drugs, formulations, and medical devices from September 22, 2025.

Natco Pharma Issues Statement on Adcock Ingram Buy

Natco Pharma Limited, a wholly owned subsidiary in South Africa, conjointly with Adcock Ingram Holdings Limited, has circulated a joint circular to the Adcock Ingram’s shareholders.

FDA Approves J&J's Inlexzo for Bladder Cancer Patients

The U.S. Food and Drug Administration (FDA) has approved Inlexzo, the first drug delivery system from Johnson & Johnson, for patients with high-risk non-muscle invasive bladder cancer who have failed standard Bacillus Calmette-Guerin (BCG) therapy...

Sun Pharmas Halol Plant Receives OAI Status from USFDA Inspection

Sun Pharmaceutical Industries declared that the US Food and Drug Administration (USFDA) has moved its Halol manufacturing plant in Gujarat to Official Action Indicated (OAI). The decision follows by the detailed examination.

Akums Expands Access to Eurasian Pharma Markets

Akums Drugs & Pharmaceuticals Ltd. has said that its Hormonal Manufacturing Plant has received a Good Manufacturing Practice (GMP) Certificate from the (BEAEU)

Takeda Wins USFDA Nod for Expanded Vonvendi Use in VWD

Takeda got an approval from the U.S. Food and Drug Administration (FDA) for the additional Biologics License Application (BLA) for VONVENDI

Making Healthcare Affordable: GST Reforms Explained

The recent GST Reform by the Government of India to exempt individual health and life insurance premiums, along with the rationalization of healthcare goods and services, marks a landmark step in its mission of achieving Affordable Healthcare and...

NPPA sets Ceiling Price for Gufic Meropenem Dual Chamber Bag

The National Pharmaceutical Pricing Authority (NPPA) has handed a special ceiling price for the product of Meropenem Powder for Injection in dual chamber bags by Gufic Biosciences Limited

Govt Removes GST on 33 Critical Life-Saving Medicines

The GST Council has removed the 12% Goods and Services Tax (GST) on 33 high-cost life-saving drugs and diagnostic kits, resulting in these items being tax-free and thus relieving the burden on patients.

on the deck

Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.